🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- IPO
- 10/30/2026 · 10.55 Million Shares @ $16.00/share
Business: Bambusa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing next-generation, long-acting precision bispecific antibodies designed to redefine standards of care in immunology and inflammation. The Company uses advanced antibody engineering, combining validated biologic pathways into single molecules formulated for high-concentration subcutaneous delivery with the goal of improving durability and convenience beyond existing monotherapies
Company Contact
- CEO
- Shanshan Xu
- CFO
- Jon Lieber
- Headquarters
- 22 Boston Wharf Road, Floor 7, Boston, MA 02210
- Phone
- 617-848-6188
- Investor Relations
- investors@bambusatx.com